Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program

Roxanne Payne; Lyn Glenn; Helena Hoen; Beverley Richards; John W Smith; Robert Lufkin; Todd S Crocenzi; Walter J Urba; Brendan D Curti

doi:10.1186/2051-1426-2-13

Article info

Research Article

Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program

Free

Authors

Roxanne Payne Providence Cancer Center, Providence Portland Medical CenterEarle A. Chiles Research Institute 4805 NE Glisan Street 97213 Portland OR USA PubMed articles Google scholar articles
Lyn Glenn Providence Cancer Center, Providence Portland Medical CenterEarle A. Chiles Research Institute 4805 NE Glisan Street 97213 Portland OR USA PubMed articles Google scholar articles
Helena Hoen Providence Cancer Center, Providence Portland Medical CenterEarle A. Chiles Research Institute 4805 NE Glisan Street 97213 Portland OR USA PubMed articles Google scholar articles
Beverley Richards Providence Cancer Center, Providence Portland Medical CenterEarle A. Chiles Research Institute 4805 NE Glisan Street 97213 Portland OR USA PubMed articles Google scholar articles
John W Smith Compass Oncology 97725 Portland 265 N BroadwayOR USA PubMed articles Google scholar articles
Robert Lufkin Compass Oncology 97725 Portland 265 N BroadwayOR USA PubMed articles Google scholar articles
Todd S Crocenzi Providence Cancer Center, Providence Portland Medical CenterEarle A. Chiles Research Institute 4805 NE Glisan Street 97213 Portland OR USA PubMed articles Google scholar articles
Walter J Urba Providence Cancer Center, Providence Portland Medical CenterEarle A. Chiles Research Institute 4805 NE Glisan Street 97213 Portland OR USA PubMed articles Google scholar articles
Brendan D Curti Providence Cancer Center, Providence Portland Medical CenterEarle A. Chiles Research Institute 4805 NE Glisan Street 97213 Portland OR USA PubMed articles Google scholar articles

↵a Roxanne.Payne{at}Providence.org
↵b Lyn.Glenn{at}Providence.org
↵c Helena.Hoen{at}Providence.org
↵d Beverley.Richards{at}Providence.org
↵e John.Smith{at}usoncology.com
↵f Robert.Lufkin{at}usoncology.com
↵g Todd.Crocenzi{at}Providence.org
↵h Walter.Urba{at}Providence.org
↵i Brendan.Curti{at}Providence.org

View Full Text

Citation

Payne R, Glenn L, Hoen H, et al

Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program

Journal for ImmunoTherapy of Cancer 2014;2:13. doi: 10.1186/2051-1426-2-13

Publication history

Received January 29, 2014
Accepted April 22, 2014
First published May 14, 2014.

Online issue publication

February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password